Kennedy Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $25.8M | Sell |
236,777
-11,130
| -4% | -$1.06M | 0.55% | 32 |
|
|
2025
Q4 | $20.1M | Buy |
247,907
+32,040
| +15% | +$2.76M | 0.43% | 56 |
|
|
2025
Q3 | $18.9M | Buy |
215,867
+51,816
| +32% | +$4.63M | 0.42% | 55 |
|
|
2025
Q2 | $13.6M | Sell |
164,051
-3,072
| -2% | -$257K | 0.32% | 86 |
|
|
2025
Q1 | $14M | Buy |
167,123
+43,307
| +35% | +$4.03M | 0.34% | 82 |
|
|
2024
Q4 | $11.4M | Buy |
123,816
+927
| +0.8% | +$89.1K | 0.25% | 115 |
|
|
2024
Q3 | $11.4M | Sell |
122,889
-73,289
| -37% | -$6.35M | 0.25% | 113 |
|
|
2024
Q2 | $16.1M | Sell |
196,178
-27,508
| -12% | -$2.02M | 0.35% | 69 |
|
|
2024
Q1 | $14.8M | Sell |
223,686
-12,723
| -5% | -$785K | 0.31% | 85 |
|
|
2023
Q4 | $13.4M | Sell |
236,409
-26,736
| -10% | -$1.4M | 0.29% | 96 |
|
|
2023
Q3 | $14.3M | Sell |
263,145
-18,172
| -6% | -$1.08M | 0.35% | 71 |
|
|
2023
Q2 | $18.9M | Sell |
281,317
-27,852
| -9% | -$1.7M | 0.44% | 40 |
|
|
2023
Q1 | $15.9M | Sell |
309,169
-13,394
| -4% | -$650K | 0.47% | 38 |
|
|
2022
Q4 | $14.8M | Buy |
322,563
+52,271
| +19% | +$2.45M | 0.42% | 55 |
|
|
2022
Q3 | $13.7M | Sell |
270,292
-20,174
| -7% | -$1.01M | 0.4% | 57 |
|
|
2022
Q2 | $13.2M | Sell |
290,466
-111,059
| -28% | -$4.97M | 0.37% | 68 |
|
|
2022
Q1 | $18.7M | Sell |
401,525
-24,420
| -6% | -$1.09M | 0.44% | 46 |
|
|
2021
Q4 | $21.4M | Sell |
425,945
-12,810
| -3% | -$662K | 0.45% | 41 |
|
|
2021
Q3 | $23.3M | Buy |
438,755
+66,628
| +18% | +$3.75M | 0.52% | 20 |
|
|
2021
Q2 | $22.7M | Sell |
372,127
-72,527
| -16% | -$3.85M | 0.49% | 23 |
|
|
2021
Q1 | $21.7M | Sell |
444,654
-3,185
| -0.7% | -$149K | 0.44% | 35 |
|
|
2020
Q4 | $18.1M | Buy |
447,839
+46,102
| +11% | +$1.65M | 0.41% | 36 |
|
|
2020
Q3 | $13.1M | Buy |
401,737
+259,817
| +183% | +$7.8M | 0.37% | 51 |
|
|
2020
Q2 | $3.75M | Sell |
141,920
-18,800
| -12% | -$491K | 0.11% | 355 |
|
|
2020
Q1 | $4M | Buy |
160,720
+1,071
| +0.7% | +$33.1K | 0.15% | 259 |
|
|
2019
Q4 | $5.74M | Sell |
159,649
-2,936
| -2% | -$101K | 0.14% | 275 |
|
|
2019
Q3 | $5.56M | Sell |
162,585
-6,970
| -4% | -$223K | 0.14% | 287 |
|
|
2019
Q2 | $4.74M | Buy |
169,555
+8,949
| +6% | +$249K | 0.11% | 344 |
|
|
2019
Q1 | $4.98M | Sell |
160,606
-15,302
| -9% | -$408K | 0.12% | 330 |
|
|
2018
Q4 | $4.16M | Buy |
+175,908
| New | +$4.8M | 0.1% | 371 |
|
|
2015
Q3 | – | Sell |
-69,180
| Closed | -$834K | – | 733 |
|
|
2015
Q2 | $834K | Sell |
69,180
-38,345
| -36% | -$377K | 0.02% | 680 |
|
|
2015
Q1 | $901K | Sell |
107,525
-76,155
| -41% | -$598K | 0.02% | 662 |
|
|
2014
Q4 | $1.41M | Sell |
183,680
-35,581
| -16% | -$255K | 0.03% | 621 |
|
|
2014
Q3 | $1.51M | Buy |
219,261
+4,661
| +2% | +$34.8K | 0.03% | 603 |
|
|
2014
Q2 | $1.77M | Buy |
214,600
+8,613
| +4% | +$67.3K | 0.03% | 574 |
|
|
2014
Q1 | $1.66M | Buy |
205,987
+5,194
| +3% | +$41.5K | 0.03% | 574 |
|
|
2013
Q4 | $1.61M | Buy |
+200,793
| New | +$1.55M | 0.03% | 590 |
|
Other funds holding LMAT
CCA
VCM
CCM
CAM
GCM
VPM
Kennedy Capital Management's LMAT Position: Q1 2026 in Review
Kennedy Capital Management reduced its LeMaitre Vascular (LMAT) stake by 4.5% in Q1 2026, selling an estimated $1.06M and leaving 236,777 shares worth $25.8M. The position accounts for 0.55% of the portfolio, ranked #32.
Kennedy Capital Management first reported a position in LMAT in Q4 2013 and has held it in 37 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.
- Kennedy Capital Management held 236,777 shares of LeMaitre Vascular worth $25.8M as of Q1 2026.
- Kennedy Capital Management sold 11,130 LeMaitre Vascular shares in Q1 2026, an estimated $1.06M.
- LeMaitre Vascular made up 0.55% of Kennedy Capital Management's portfolio in Q1 2026, its #32 holding.
- Kennedy Capital Management first reported a position in LeMaitre Vascular in Q4 2013 and has held it in 37 quarters since.
- 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.
Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.